Abbot Recalls HeartMate 3 Left Ventricular Assist Device Over Possible Malfunction Risk

Abbott Laboratories, a world-renowned health care medical technology company, has issued a recall for the HeartMate 3 Left Ventricle Assist Device. The heart device has been used extensively at the Cleveland Clinic and University Hospitals to assist patients with heart failure issues. As Abbott has informed doctors and medical professionals worldwide, the problems associated with…

Read More

Opioid Antidote Naloxone Recalled by Manufacturer

Drug manufacturer Hospira has recalled Naloxone, the medication commonly used by first responders, medical professionals, and hospitals to quickly reverse suspected conditions of an opioid overdose. The National Institute on Drug Abuse states that Naloxone works as an opioid antagonist, attaching to opioid receptors in the brain. Therefore, when it is administered to a drug…

Read More

Voluntary Withdrawal of Zinbryta from the Market After Concerns Arise Over Liver and Brain Damage

The drug Zinbryta has been recalled on a voluntary basis by its manufacturers according to the recommendation of the European Medicines Agency (EMA) in cooperation with the Food & Drug Administration (FDA). Zinbryta (daclizumab) was approved by the FDA in May 2016 for the treatment of individuals suffering from various relapses of multiple sclerosis (MS).…

Read More

Uloric Whistleblower Lawsuits Allege the Manufacturer Withheld Dangerous Side Effect Information

First introduced onto the market in February 2009, Uloric (febuxostat), manufactured by Takeda Pharmaceuticals, was the first medication formulated to treat gout in more than four decades. However, not long after its introduction, many individuals have come forward with reports of serious side effects from using the drug. Uloric and the treatment of gout Uloric…

Read More

Ocaliva Dosage Errors Prompt the FDA to Require New Black Box Warning

FDA officials have now added a boxed warning label to obeticholic acid (Ocaliva), a liver disease medicine, in order to emphasize the proper dosing patients with rare chronic liver disease should follow. The FDA announcement states that the designated daily dosage for obeticholic acid, manufactured by Intercept Pharmaceuticals, has been incorrect. Instead, the dosage has…

Read More

Nuplazid Produced Worsening Conditions for Many Users

Anti-psychotic drug Nuplazid (pimavanserin) is manufactured by Acadia pharmaceuticals and approved by the Federal Drug Administration (FDA) for treating Parkinson’s disease patients with debilitating psychosis. The process of approval used for Nuplazid allowed an expedited pharmaceutical safety review by categorizing this drug as a breakthrough therapy. Instituted by Congress in 2012, this breakthrough therapy classification…

Read More

Warning: These Teething Medicines Are Unsafe for Your Baby

The U.S. Food and Drug Administration (FDA) is warning consumers about an over-the-counter teething medication for infants and children under the age of two that could be harmful. The agency says that products containing benzocaine are dangerous and pose a serious risk to infants and children under two. Benzocaine is used to treat sore gums,…

Read More